Etiologic heterogeneity among non-Hodgkin lymphoma subtypes

被引:130
作者
Morton, Lindsay M. [1 ]
Wang, Sophia S.
Cozen, Wendy [2 ]
Linet, Martha S.
Chatterjee, Nilanjan
Davis, Scott [3 ,4 ]
Severson, Richard K. [5 ,6 ]
Colt, Joanne S.
Vasef, Mohammad A. [7 ]
Rothman, Nathaniel
Blair, Aaron
Bernstein, Leslie [8 ,9 ]
Cross, Amanda J.
De Roos, Anneclaire J. [3 ,4 ]
Engels, Eric A.
Hein, David W. [10 ,11 ]
Hill, Deirdre A. [12 ,13 ]
Kelemen, Linda E. [14 ]
Lim, Unhee
Lynch, Charles F. [15 ]
Schenk, Maryjean [5 ,6 ]
Wacholder, Sholom
Ward, Mary H.
Zahm, Shelia Hoar
Chanock, Stephen J. [16 ]
Cerhan, James R. [14 ]
Hartge, Patricia
机构
[1] NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Rockville, MD 20852 USA
[2] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA
[3] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[4] Univ Washington, Seattle, WA 98195 USA
[5] Wayne State Univ, Dept Family Med, Detroit, MI USA
[6] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
[7] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA
[8] City Hope Comprehens Canc Ctr, Duarte, CA USA
[9] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA
[10] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA
[11] Univ Louisville, Sch Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA
[12] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA
[13] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA
[14] Mayo Clin, Coll Med, Rochester, MN USA
[15] Univ Iowa, Dept Epidemiol, Iowa City, IA USA
[16] NCI, Core Genotyping Facil, Adv Technol Ctr, NIH, Gaithersburg, MD USA
基金
美国国家卫生研究院;
关键词
D O I
10.1182/blood-2008-01-133587
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Understanding patterns of etiologic commonality and heterogeneity for non-Hodgkin lymphomas may illuminate lymphomagenesis. We present the first systematic comparison of risks by lymphoma subtype for a broad range of putative risk factors in a population-based case-control study, including diffuse large B-cell (DLBCL; N = 416), follicular (N = 318), and marginal zone lymphomas (N = 106), and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL; N = 133). We required at least 2 of 3 analyses to support differences in risk: (1) polytomous logistic regression, (2) homogeneity tests, or (3) dichotomous logistic regression, analyzing all 7 possible pairwise comparisons among the subtypes, corresponding to various groupings by clinical behavior, genetic features, and differentiation. Late birth order and high body mass index (>= 35) kg/m(2)) increased risk for DLBCL alone. Autoimmune conditions increased risk for marginal zone lymphoma alone. The tumor necrosis factor G-308A polymorphism (rs1800629) increased risks for both DLBCL and marginal zone lymphoma. Exposure to certain dietary heterocyclic amines from meat consumption increased risk for CLL/SLL alone. We observed no significant risk factors for follicular lymphoma alone. These data clearly support both etiologic commonality and heterogeneity for lymphoma subtypes, suggesting that immune dysfunction is of greater etiologic importance for DLBCL and marginal zone lymphoma than for CLL/SLL and follicular lymphoma. (Blood. 2008; 112: 5150-5160)
引用
收藏
页码:5150 / 5160
页数:11
相关论文
共 69 条
  • [1] The non-Hodgkin lymphomas: A review of the epidemiologic literature
    Alexander, Dominik D.
    Mink, Pamela J.
    Adami, Hans-Olov
    Chang, Ellen T.
    Cole, Philip
    Mandel, Jack S.
    Trichopoulos, Dimitrios
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2007, : 1 - 39
  • [2] Number of siblings and the risk of lymphoma, leukemia, and myeloma by histopathology
    Altieri, Andrea
    Castro, Felipe
    Bermejo, Justo Lorenzo
    Hemminki, Kari
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (07) : 1281 - 1286
  • [3] METHODS FOR DETECTING CARCINOGENS AND MUTAGENS WITH SALMONELLA-MAMMALIAN-MICROSOME MUTAGENICITY TEST
    AMES, BN
    MCCANN, J
    YAMASAKI, E
    [J]. MUTATION RESEARCH, 1975, 31 (06): : 347 - 363
  • [4] Are vitamin and mineral deficiencies a major cancer risk?
    Ames, BN
    Wakimoto, P
    [J]. NATURE REVIEWS CANCER, 2002, 2 (09) : 694 - 704
  • [5] [Anonymous], CANC EPIDEMIOLOGY PR
  • [6] Is there a future for TNF promoter polymorphisms?
    Bayley, JP
    Ottenhoff, THM
    Verweij, CL
    [J]. GENES AND IMMUNITY, 2004, 5 (05) : 315 - 329
  • [7] Birth order, allergies and lymphoma risk:: Results of the European collaborative research project Epilymph
    Becker, Nikolaus
    de Sanjose, Silvia
    Nieters, Alexandra
    Maynadie, Marc
    Foretova, Lenka
    Cocco, Pier Luigi
    Staines, Anthony
    Alvaro, Tomas
    Vornanen, Martine
    Brennan, Paul
    Boffetta, Paolo
    [J]. LEUKEMIA RESEARCH, 2007, 31 (10) : 1365 - 1372
  • [8] Residential history, family characteristics and non-Hodgkin lymphoma, a population-based case-control study in the San Francisco bay area
    Bracci, Paige M.
    Dalvi, Tapashi B.
    Holly, Elizabeth A.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (07) : 1287 - 1294
  • [9] Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms
    Calle, EE
    Kaaks, R
    [J]. NATURE REVIEWS CANCER, 2004, 4 (08) : 579 - 591
  • [10] Anthropometrics, physical activity, related medical conditions, and the risk of non-Hodgkin lymphoma
    Cerhan, JR
    Bernstein, L
    Severson, RK
    Davis, S
    Colt, JS
    Blair, A
    Hartge, P
    [J]. CANCER CAUSES & CONTROL, 2005, 16 (10) : 1203 - 1214